De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
about
Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics.Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.
P2860
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@en
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@nl
type
label
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@en
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@nl
prefLabel
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@en
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@nl
P2093
P2860
P356
P1433
P1476
De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2013.37
P50
P577
2013-06-27T00:00:00Z